Repaglinide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Repaglinide.
| Product ID | 60687-560_ac1315f0-ca96-13ec-e053-2a95a90ad2a3 |
| NDC | 60687-560 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Repaglinide |
| Generic Name | Repaglinide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-08-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203820 |
| Labeler Name | American Health Packaging |
| Substance Name | REPAGLINIDE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-3122 | Repaglinide | repaglinide |
| 0378-3123 | Repaglinide | repaglinide |
| 0574-0240 | Repaglinide | REPAGLINIDE |
| 0574-0241 | Repaglinide | REPAGLINIDE |
| 0574-0242 | Repaglinide | REPAGLINIDE |
| 51079-539 | Repaglinide | repaglinide |
| 51991-853 | REPAGLINIDE | REPAGLINIDE |
| 51991-854 | REPAGLINIDE | REPAGLINIDE |
| 51991-855 | REPAGLINIDE | REPAGLINIDE |
| 57237-157 | Repaglinide | Repaglinide |
| 57237-158 | Repaglinide | Repaglinide |
| 57237-159 | Repaglinide | Repaglinide |
| 57664-745 | Repaglinide | Repaglinide |
| 57664-747 | Repaglinide | Repaglinide |
| 60429-484 | REPAGLINIDE | REPAGLINIDE |
| 60429-485 | REPAGLINIDE | REPAGLINIDE |
| 60429-486 | REPAGLINIDE | REPAGLINIDE |
| 68084-967 | Repaglinide | Repaglinide |
| 68084-954 | Repaglinide | Repaglinide |
| 65862-670 | Repaglinide | Repaglinide |
| 65862-671 | Repaglinide | Repaglinide |
| 65862-672 | Repaglinide | Repaglinide |
| 0169-0081 | Prandin | repaglinide |
| 0169-0082 | Prandin | repaglinide |
| 0169-0084 | Prandin | repaglinide |